Skip to main content
. 2021 May 6;80(8):1022–1030. doi: 10.1136/annrheumdis-2020-219717

Figure 2.

Figure 2

(A) Proportion of flare-free patients through week 64. P value vs withdrawn to placebo: *p<0.05, †p<0.01, ‡p<0.001. (B) Proportion of flare-free patients at week 64 in patient subgroups with radiographic axial spondyloarthritis (r-axSpA) and non-radiographic axial spondyloarthritis (nr-axSpA).